Epidemiology of Treated Epilepsy in New Zealand Children A Focus on Ethnicity
Shayma Ali, James Stanley, Suzanne Davis, Ngaire Keenan, Ingrid Eileen Scheffer, Lynette Grant Sadleir
NEUROLOGY | LIPPINCOTT WILLIAMS & WILKINS | Published : 2021
BACKGROUND AND OBJECTIVES: To determine the period prevalence and incidence of treated epilepsy in a New Zealand pediatric cohort with a focus on ethnicity and socioeconomic status. METHODS: This was a retrospective cohort study. The New Zealand Pharmaceutical Collection database was searched for individuals ≤18 years of age dispensed an antiseizure medication (ASM) in 2015 from areas capturing 48% of the New Zealand pediatric population. Medical records of identified cases were reviewed to ascertain the indication for the ASM prescription. Population data were derived from the New Zealand 2013 Census. RESULTS: A total of 3,557 ASMs were prescribed during 2015 in 2,594 children, of whom 1,71..View full abstract
The authors thank the Ministry of Health, New Zealand, for conducting the search and supplying the information from the Pharmaceutical Collection database and Statistics New Zealand for providing regional population data. S. Ali thanks Freemasons New Zealand for their financial support.